Education
About Us
Working with TipRanks
Follow Us
Sunshine Biopharma, Inc. (SBFM)
:SBFM
SBFM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.17 - $3.90
Previous CloseN/A
Volume70.59K
Average Volume (3M)50.32K
Market Cap
$6.56M
Enterprise Value-$2.89M
Total Cash (Recent Filing)$9.69M
Total Debt (Recent Filing)$952.48K
Price to Earnings (P/E)―
Beta1.43
Next Earnings
Nov 11, 2025EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding4,555,945
10 Day Avg. Volume41,758
30 Day Avg. Volume50,323
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap-0.44
Enterprise Value/Revenue-0.08
Enterprise Value/Gross Profit-0.27
Enterprise Value/Ebitda0.57
Forecast
1Y Price Target
$1.50Price Target Upside4.17% Upside
Rating ConsensusHold
Number of Analyst Covering0
Sunshine Biopharma News
SBFM FAQ
What was Sunshine Biopharma, Inc.’s price range in the past 12 months?
Sunshine Biopharma, Inc. lowest stock price was $1.17 and its highest was $3.90 in the past 12 months.
What is Sunshine Biopharma, Inc.’s market cap?
Sunshine Biopharma, Inc.’s market cap is $6.56M.
When is Sunshine Biopharma, Inc.’s upcoming earnings report date?
Sunshine Biopharma, Inc.’s upcoming earnings report date is Nov 11, 2025 which is in 68 days.
How were Sunshine Biopharma, Inc.’s earnings last quarter?
Sunshine Biopharma, Inc. released its earnings results on Jul 30, 2025. The company reported -$0.394 earnings per share for the quarter, missing the consensus estimate of -$0.11 by -$0.284.
Is Sunshine Biopharma, Inc. overvalued?
According to Wall Street analysts Sunshine Biopharma, Inc.’s price is currently Undervalued.
Does Sunshine Biopharma, Inc. pay dividends?
Sunshine Biopharma, Inc. does not currently pay dividends.
What is Sunshine Biopharma, Inc.’s EPS estimate?
Sunshine Biopharma, Inc.’s EPS estimate is -0.09.
How many shares outstanding does Sunshine Biopharma, Inc. have?
Sunshine Biopharma, Inc. has 4,555,945 shares outstanding.
What happened to Sunshine Biopharma, Inc.’s price movement after its last earnings report?
Sunshine Biopharma, Inc. reported an EPS of -$0.394 in its last earnings report, missing expectations of -$0.11. Following the earnings report the stock price went down -2.649%.
Which hedge fund is a major shareholder of Sunshine Biopharma, Inc.?
Currently, no hedge funds are holding shares in SBFM
Company Description
Sunshine Biopharma, Inc.
Sunshine Biopharma (SBFM) is a biopharmaceutical company focused on the development of innovative therapies for the treatment of cancer and other serious diseases. The company operates in the biotechnology sector, specializing in the research, development, and commercialization of novel drug candidates. SBFM's core products include proprietary compounds targeting various types of cancers, with an emphasis on addressing unmet medical needs through advanced therapeutic solutions.
Technical Analysis
China Pharma Holdings
―
Sonoma Pharmaceuticals
―
Evoke Pharma
―
RedHill Biopharma
―
PainReform
―
Ownership Overview
1.11% Insiders
<0.01% Mutual Funds
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---